BGI Genomics’ COVID-19 Test Gets Canadian Authorization

BGI Genomics received authorization from Health Canada to distribute its real-time fluorescent COVID-19 polymerase chain reaction test in Canada.

The diagnostic tests respiratory samples for coronavirus RNA and produces results within three hours.

The company said it can manufacture 2 million tests per day and is handling orders from more than 80 countries.